Arbutus Biopharma Corp: Form 20-F for the period ended Dec 31, 2012
Filed with the SEC on Mar 27, 2013 and accepted by EDGAR at Mar 27, 2013, 16:59 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2012-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Diluted shares (weighted) | 12 months2012-01-01 to 2012-12-31 | 14,320,814 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Shares outstanding | At period end2012-12-31 | 14,305,356 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001193125-13-129590. Last ingested by Listed: Nov 12, 2026, 17:55 ET. Listed shows no prices and gives no investment advice.